FDAJune 16, 2025device

InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Medtronic MiniMed, Inc. is recalling InPen App for iOS and Android users due to software design errors that could lead to a missed short-acting insulin dose reminder and a recommendation to correct a high glucose value. It does not impact insulin delivery, long-acting insulin dose reminders, or CGM alerts, and users can still use the pen itself to calculate a dose, deliver insulin, record the dose date/time, and view CGM data. This issue was identified during internal testing before release in the US but after release to OUS customers, no complaints or MDRs related to this recall have been reported. Use of the affected device may result hyperglycemia by failing to alert the user and delay treatment of diabetes.

What to do

FDA enforcement status: Ongoing

Brands named

medtronic minimedmedtronic

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →
InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users) — Recall Details · AllClear